Evidence map›Paper›PMID 29855315›Full record

Trial reportBMC health services research2018

Medical oncologists' willingness to participate in bundled payment programs.

Yonina R Murciano-Goroff, Anne Marie McCarthy, Mirar N Bristol, Susan M Domchek, Peter W Groeneveld, U Nkiru Motanya, Katrina Armstrong

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMC health services research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yonina R Murciano-GoroffDepartment of Medicine, Massachusetts General Hospital, 55 Fruit Street, GRB 740, Boston, MA, 02114, USA. ymurciano-goroff@partners.org.
Anne Marie McCarthyDepartment of Medicine, Massachusetts General Hospital, 55 Fruit Street, GRB 740, Boston, MA, 02114, USA.
Mirar N BristolDepartment of Medicine, Massachusetts General Hospital, 55 Fruit Street, GRB 740, Boston, MA, 02114, USA.
Susan M DomchekUniversity of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA.
Peter W GroeneveldDepartment of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
U Nkiru MotanyaDepartment of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Katrina ArmstrongDepartment of Medicine, Massachusetts General Hospital, 55 Fruit Street, GRB 740, Boston, MA, 02114, USA.
Massachusetts General Hospital · USUniversity of Pennsylvania · US

Funding

Racial Differences in BRCA1/2 Testing: Patients or Providers?R01CA133004 · NCI · UNIVERSITY OF PENNSYLVANIA · PI GROENEVELD, PETER W. · 2009 to 2013
$2.5M
NCI NIH HHS 5-R01-CA133004NCI NIH HHS R01 CA133004
6 · The paper itself

Abstract

backgroundBundled payment programs play an increasingly important role in transforming reimbursement for oncologic care. We assessed determinants of oncologists' willingness to participate in bundled payment programs for breast cancer. We hypothesized that providers would be more likely to participate in bundled payment programs if offered higher levels of reimbursement for each episode of care.

methodsOncologists from Florida, New Jersey, New York, and Pennsylvania were identified in the AMA database or by patients listed in state cancer registries. Providers were randomized to receive one of four versions of a survey describing bundled payment programs offering different levels of compensation for the first year of localized breast cancer treatment ($5000, $10,000, $15,000, or $20,000). Physicians rated their likelihood of participation in a bundled program on a Likert scale. Logistic regression was used to analyze determinants of likelihood of participation in bundling.

resultsAmong 460 respondents, only 17% of oncologists were highly likely to participate in a bundled program paying $5000 for the first year of care, rising to 41% for the $15,000 program, but falling to 34% for the $20,000 program. Likelihood of participation was higher among oncologists who were male, older, and believed that cancer patients should not be offered high-cost drugs with minimal survival benefit.

conclusionOur results suggest that medical oncologists have limited enthusiasm for bundled payments, and higher payments may not overcome resistance to bundling among a substantial proportion of physicians.

Indexed as

Reimbursement MechanismsAdultAgedAged, 80 and overBreast NeoplasmsDrug CostsFemaleFloridaHealth ExpendituresHumansLogistic ModelsMaleMedical OncologyMiddle AgedNew JerseyNew YorkBreast cancerBundled paymentOncologyPayment reformPhysician compensation

Identifiers

PMID29855315
PMCPMC5984411
OpenAlexW2806350129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.